Podcast Episodes
Back to SearchE45: TNF or TCZ or ABA or RTX: Real World Data for RA
Episode 46
This week I tackle an interesting cohort study that Jack Cush (@RheumNow) mentioned in his podcast. It's a nice opportunity to discuss bDMARDs in th…
6 years, 8 months ago
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Episode 45
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) agains…
6 years, 8 months ago
E43: Tofacitinib for MDA5 Amyopathic Dermatomyositis ILD
Episode 44
Back this week to discuss an interesting paper in the NEJM. Lots of interesting issues, most notably historical controls and their limitations. Fin…
6 years, 8 months ago
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
Episode 43
This week I'll discuss an important paper in systemic sclerosis, the recent SENSCIS trial that compared 150mg nitedanib to placebo. I wind up coming…
6 years, 9 months ago
E41: Rheum4Debate "SLE Pts. on Cytoxan Should Receive Bactrim"
Episode 42
Welcome back! This is the second episode of Rheum4Debate, an oxford-style debate show for the field of rheumatology. In this podcast we'll tackle t…
6 years, 9 months ago
E40: Rheum4Debate - "SCT is 1st Line Tx for SSc ILD"
Episode 41
Exciting episode this week! This is the FIRST of a new podcast series entitled Rheum4Debate, an Oxford style debate show for the field of rheumatolo…
6 years, 11 months ago
E39: MTX for GCA - 3 RCTs and a Case Control Study
Episode 40
This week a nice case control study out of Mayo challenged my own bias against MTX in GCA. This prompted a deep dive into the literature, including …
6 years, 11 months ago
E38: Romosozumab for Osteoporosis
Episode 39
The FDA recently approved romosozumab for high risk post menopausal osteoporosis, but gave it a black box warning for cardiovascular disease. This w…
6 years, 11 months ago
E37: TRACE-RA Atorvastatin for Primary Prevention of CVD in RA
Episode 38
This week I pair the recently published TRACE-RA trial assessing the efficacy of atorvastatin in primary prevention of cardiovascular disease. It off…
7 years ago
E36: Baricitinib for SLE
Episode 37
This week I discuss the phase 2 trial on baricitinib in SLE. Though it's early times (and the total flop of rituxan in ME/CFS recently can attest to…
7 years ago